Prompt is a major advancement in evaluating a man’s genetic predisposition to prostate cancer. This simple test, performed with a cheek swab sample, at any age, can help men know their individual risk for prostate cancer and may identify high-risk men who might benefit most from prostate cancer screening.
Prostate cancer screening rates are on the decline, at the same time we are seeing an increase in the numbers of patients presenting with incurable disease. Our genetic test can help identify those men at highest risk to prompt them and their physicians to take action by getting screened and treated before it is too late.
A. Karim Kader, MD, PhD Founder, Head of Urologic Oncology at University of California, San Diego